Advertisement
Canada markets closed

  • S&P/TSX

    22,059.03
    -184.99 (-0.83%)
     

  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     

  • DOW

    39,375.87
    +67.87 (+0.17%)
     

  • CAD/USD

    0.7332
    -0.0015 (-0.20%)
     

  • CRUDE OIL

    83.44
    -0.44 (-0.52%)
     

  • Bitcoin CAD

    77,156.05
    +2,863.89 (+3.85%)
     

  • CMC Crypto 200

    1,175.23
    -33.46 (-2.77%)
     

  • GOLD FUTURES

    2,399.80
    +30.40 (+1.28%)
     

  • RUSSELL 2000

    2,026.73
    -9.90 (-0.49%)
     

  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     

  • NASDAQ

    18,352.76
    +164.46 (+0.90%)
     

  • VOLATILITY

    12.48
    +0.22 (+1.79%)
     

  • FTSE

    8,203.93
    -37.33 (-0.45%)
     

  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     

  • CAD/EUR

    0.6762
    -0.0030 (-0.44%)
     

Elanco Animal Health (ELAN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2 min read

Elanco Animal Health Incorporated (ELAN) reported $1.21 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 4.1%. EPS of $0.34 for the same period compares to $0.45 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of +2.69%. The company delivered an EPS surprise of +30.77%, with the consensus EPS estimate being $0.26.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Total Pet Health: $639 million compared to the $616.09 million average estimate based on three analysts. The reported number represents a change of -5.3% year over year.

  • Revenue- Total Farm Animal: $556 million compared to the $552 million average estimate based on three analysts. The reported number represents a change of -3% year over year.

  • Revenue- Total Contract Manufacturing: $10 million versus the two-analyst average estimate of $8.03 million. The reported number represents a year-over-year change of +11.1%.

View all Key Company Metrics for Elanco Animal Health here>>>

Shares of Elanco Animal Health have returned -11.5% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Elanco Animal Health Incorporated (ELAN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research